*By Michael Teich*
Ethical issues could be the Achilles heel for Juul, the $15 billion company behind the vaping devices infiltrating college and high school campuses.
"The valuation is justified on the math," said Dan Primack, Business Editor at Axios. The real question, though, is, "Does it want to stop kids from getting these?"
The sleek and colorful design of the company's e-cigarettes, paired with appealing flavors such as mango and cool mint, has helped Juul emerge as a leader in the market with a 68 percent share, according to Wells Fargo. The company projects $940 million in revenue this year, but Primack said he's told that "they are blowing through those numbers." Those numbers helped Juul raise a fresh $1.2 billion in new funding last week.
But strong sales growth may not be enough to entice more traditional Silicon Valley investors to overlook the moral complexities of Juul's business, Primack said.
While the device was created as an alternative to cigarettes, he pointed out the product is falling into the hands of first-time smokers and serves as a "gateway smoke."
For the full segment, [click here.](https://cheddar.com/videos/the-ethical-issues-that-may-plague-juuls-future)
Meridith McGraw, White House Reporter at The Wall Street Journal, breaks down Trump’s $200M ballroom plan, D.C. police tensions, and the future of MAGA.
After years of being told that red wine was good for heart health, more Americans appear to be heeding warnings that even moderate alcohol consumption can be unhealthy.
Amazon is now rolling out a service where its Prime members can order their blueberries and milk at the same time as their batteries and other basic items.
Dr. Richard Besser, President & CEO of the Robert Wood Johnson Foundation and former CDC acting director, unpacks the impact of RFK's mRNA funding cuts.
Jessica Inskip, Director of Investor Research at StockBrokers.com and host of MarketMakeHer, unpacks earnings, market outlook, and what history says is next.
